Event-Driven Stocks

Baudax Bio, Inc.

Healthcare · Pharmaceutical Preparations · PA · SEC filings ↗ · Compare ⊕

Signs● 3 good● 4 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY22FY21FY20FY19FY18
Revenue$1.3M$1.1M$493,000——
Operating income−$56.8M−$19.0M−$74.8M−$32.5M−$73.5M
Net income−$58.8M−$19.8M−$76.1M−$32.6M−$73.7M
Total assets$10.0M$53.3M$68.7M$54.2M$35.0M
Total liabilities$34.3M$40.1M$83.5M$70.9M$103.4M
Equity−$24.2M$13.2M−$14.8M−$16.7M−$68.3M
EPS (diluted)$-177.30$-361.16———
Shares out.6.4M70.1M9.4M9.4M—

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
−4477.0%
Net margin
−4633.2%
Return on equity
242.5%
Return on assets
−586.1%
Return on capital (ROCE)
—
Liabilities / assets
341.6%
Debt / equity
—
Book value / share
$-3.78
Revenue growth (YoY)
17.5%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
-110.72distress
Accruals / assets
−309.0%clean
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
45
/ 100
Profitability 25Growth 100Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 4 warning● 3 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)